This compound is primarily used in biomedical research to study targeted protein degradation. It functions as a PROTAC (Proteolysis Targeting Chimera) molecule, specifically designed to degrade BRD4, a protein involved in regulating gene expression. By facilitating the degradation of BRD4, it helps researchers investigate the role of this protein in various diseases, particularly cancer. Its application is crucial in understanding the mechanisms of epigenetic regulation and developing potential therapeutic strategies for conditions where BRD4 overexpression plays a critical role. Additionally, it serves as a valuable tool in drug discovery, aiding in the identification of novel targets for cancer treatment.